arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

QUEST DIAGNOSTICS INC

DGX
$254.68 ▼ -0.84 (-0.33%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
20 Visible periods
33 Metrics
Peer-ranked Benchmarks
Price Chart
68
Health
Good
Bullish
auto_awesome

Analytical Summary

QUEST DIAGNOSTICS INC shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $28.3B
Dividend Yield —
Revenue Growth 11.8% ↗
Op. Margin 14.1% ↗
ROIC 9.6% ↗
FCF / Share $12.24 ↗
Trailing P/E 28.7x
Price / Book 3.9x
FCF Yield 4.8%
Debt / Equity 0.79
info Valuation on last close. End-of-day price, Nov 5, 2026.

20-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$11.04B
↑ +11.8% —
Net Income Profit after all expenses
$992.00M
↑ +13.9% —
Operating Margin Operating profit as % of sales
14.1%
↑ +3.4% 65th
FCF / Share Free cash flow per share
$12.24
↑ +49.5% —
Long-Term Debt Long-term obligations
$5.67B
↓ -8.8% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↓
65
Returns ↓
78
Financial Health →
55
Cash Quality ↑
78

Dividend History

Dividend / share · sourced from SEC filings
$1.80 Latest / share
+9.1% YoY
+10.9% 4-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 20 years · 76 quarters